NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Twig Bio

Twig Bio

Private
LondonHealthcare & Life Scienceshttps://twig.bio/

Last Round

Grant

Apr 16, 2026

Total Funding Raised

$5.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Twig Bio is a bioengineering company that utilizes an AI-first approach to develop sustainable, eco-friendly alternatives to ingredients used in everyday consumer goods.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Application

Keywords

cell engineeringsynthetic biologybioengineeringregenerative medicinedrug discoverybio-designhigh-throughput screeningfoundryAI-driven biologyfermentationstrain engineeringbiotech platformdry labwet lab automationfoundation model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Twig Bio Comps

Public and private peers based on sector, stage, and business model.

Twig Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Twig Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 16, 2026
GrantJul 1, 2025
GrantMar 21, 2025
GrantFeb 14, 2024
SeedSep 11, 2023

Key People

Founding team and executive leadership

Satnam Surae

Co-founder And CTO

Founding Team

Russ Tucker

Co-Founder And CEO

Founding Team

Twig Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Announced CANOPY, a foundation model for AI-driven strain design.

  • Sep 11, 2023

    $4M raised from Gaingels, Project A, and Seedcamp.

Twig Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Twig Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Twig Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range18
Year Founded2022
Last FundingApr 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.